INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 452m ago
HOUSE PTR52m ago
SEC 13F52m ago
ROBINHOOD CHAIN51m ago
Public company

TNXPTonix Pharmaceuticals Holding Corp.

CIK 0001430306

EDGAR filingsOpen in network
Disclosed transactions21
Buys / sells3 / 0
Max Insider Score44
Connections15with evidence

TNXP · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
41
BH
Bagger Richard HDirector
TNXPTonix Pharmaceuticals Holding Corp.
Open-market purchase
BUY$13K
1,000 sh
Aug 20, 2026Aug 24, 2026
traded Aug 20, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Lobbied forevidence
    BURRELL INTERNATIONAL GROUP LLCLDA Q2 2026 second quarter · Pharmacy · Aug 26, 2026
  • ← Insider ofevidence
    Olukotun Adeoye YDirector · May 14, 2026
  • ← Insider ofevidence
    Bell Margaret SmithDirector · May 14, 2026
9
SN
Stillwell Richard NewcombDirector
TNXPTonix Pharmaceuticals Holding Corp.
Grant or award
A
—
22.7K sh
May 12, 2026
May 14, 2026
traded May 12, 2026
+2d
SEC FORM 4

Evidence

9
OY
Olukotun Adeoye YDirector
TNXPTonix Pharmaceuticals Holding Corp.
Grant or award
A—
22.7K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC FORM 4

Evidence

9
BS
Bell Margaret SmithDirector
TNXPTonix Pharmaceuticals Holding Corp.
Grant or award
A—
22.7K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC FORM 4

Evidence

9
HR
Hunter James Randolph JrDirector
TNXPTonix Pharmaceuticals Holding Corp.
Grant or award
A—
22.7K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC FORM 4

Evidence

9
TJ
Treco JamesDirector
TNXPTonix Pharmaceuticals Holding Corp.
Grant or award
A—
22.7K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC FORM 4

Evidence

9
GL
Grange David LDirector
TNXPTonix Pharmaceuticals Holding Corp.
Grant or award
A—
22.7K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC FORM 4

Evidence

9
BH
Bagger Richard HDirector
TNXPTonix Pharmaceuticals Holding Corp.
Grant or award
A—
22.7K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC FORM 4

Evidence

9
TE
Taylor Carolyn E.Director
TNXPTonix Pharmaceuticals Holding Corp.
Grant or award
A—
22.7K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC FORM 4

Evidence

36
LS
Lederman SethDirector, Chief Executive Officer
TNXPTonix Pharmaceuticals Holding Corp.
Open-market purchase
BUY$63K
5,000 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC FORM 4

Evidence

44
LS
Lederman SethDirector, Chief Executive Officer
TNXPTonix Pharmaceuticals Holding Corp.
Open-market purchase
BUY$223K
15.0K sh
Mar 18, 2026Mar 18, 2026
traded Mar 18, 2026
+0dSEC FORM 4

Evidence

9
ME
Morris Jessica EdgarChief Operating Officer
TNXPTonix Pharmaceuticals Holding Corp.
Grant or award
A—
39.0K sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC FORM 4

Evidence

9
ME
Morris Jessica EdgarChief Operating Officer
TNXPTonix Pharmaceuticals Holding Corp.
Grant or award
A—
39.0K sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC FORM 4

Evidence

9
SB
Saenger BradleyChief Financial Officer
TNXPTonix Pharmaceuticals Holding Corp.
Grant or award
A—
39.0K sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC FORM 4

Evidence

9
SM
Sullivan Gregory MChief Medical Officer
TNXPTonix Pharmaceuticals Holding Corp.
Grant or award
A—
39.0K sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC FORM 4

Evidence

9
FS
Fogarty SiobhanChief Technology Officer
TNXPTonix Pharmaceuticals Holding Corp.
Grant or award
A—
39.0K sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC FORM 4

Evidence

9
FS
Fogarty SiobhanChief Technology Officer
TNXPTonix Pharmaceuticals Holding Corp.
Grant or award
A—
39.0K sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC FORM 4

Evidence

9
LS
Lederman SethDirector, Chief Executive Officer
TNXPTonix Pharmaceuticals Holding Corp.
Grant or award
A—
134.5K sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC FORM 4

Evidence

9
LS
Lederman SethDirector, Chief Executive Officer
TNXPTonix Pharmaceuticals Holding Corp.
Grant or award
A—
134.5K sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC FORM 4

Evidence

9
SM
Sullivan Gregory MChief Medical Officer
TNXPTonix Pharmaceuticals Holding Corp.
Grant or award
A—
39.0K sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC FORM 4

Evidence

9
SB
Saenger BradleyChief Financial Officer
TNXPTonix Pharmaceuticals Holding Corp.
Grant or award
A—
39.0K sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Hunter James Randolph JrDirector · May 14, 2026
  • ← Insider ofevidence
    Treco JamesDirector · May 14, 2026
  • ← Insider ofevidence
    Grange David LDirector · May 14, 2026
  • ← Insider ofevidence
    Taylor Carolyn E.Director · May 14, 2026
  • ← Insider ofevidence
    Stillwell Richard NewcombDirector · May 14, 2026
  • ← Insider ofevidence
    Bagger Richard HDirector · May 14, 2026
  • ← Insider ofevidence
    Saenger BradleyChief Financial Officer · Feb 26, 2026
  • ← Insider ofevidence
    Sullivan Gregory MChief Medical Officer · Feb 26, 2026
  • ← Insider ofevidence
    Fogarty SiobhanChief Technology Officer · Feb 26, 2026
  • ← Insider ofevidence
    Lederman SethDirector, Chief Executive Officer · Feb 26, 2026
  • ← Insider ofevidence
    Morris Jessica EdgarChief Operating Officer · Feb 26, 2026

    • Lobbying

    $80K reported · de-duplicated
    2026 Q2 $40K via firms2026 Q1 $40K via firms
    • BURRELL INTERNATIONAL GROUP LLC$40K2026 Q1 · posted Aug 26, 2026 · Pharmacy
    • BURRELL INTERNATIONAL GROUP LLC$40K2026 Q2 · posted Aug 26, 2026 · Pharmacy

    Connected PAC contributions

    FEC · direct to members

    No contributions from a PAC connected to this company.